| Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary | Journal of Gastroenterology and Hepatology (Australia) | 2007 | 328 |
| NAFLD in Asia--as common and important as in the West | Nature Reviews Gastroenterology and Hepatology | 2013 | 321 |
| NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications | Gut and Liver | 2012 | 278 |
| Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines | Journal of Gastroenterology and Hepatology (Australia) | 2007 | 227 |
| Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment | Journal of Gastroenterology and Hepatology (Australia) | 2018 | 211 |
| What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? | Journal of Gastroenterology and Hepatology (Australia) | 2007 | 196 |
| Hepatic microcirculation in fatty liver disease | Anatomical Record | 2008 | 183 |
| A fresh look at NASH pathogenesis. Part 1: the metabolic movers | Journal of Gastroenterology and Hepatology (Australia) | 2010 | 132 |
| Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground | Journal of Gastroenterology and Hepatology (Australia) | 2011 | 124 |
| Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines | Hepatology | 2007 | 112 |
| Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis | Hepatology | 2019 | 107 |
| Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice | Biochemical and Biophysical Research Communications | 2006 | 99 |
| ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytes | Nature Immunology | 2011 | 98 |
| Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression | Journal of Gastroenterology and Hepatology (Australia) | 2009 | 97 |
| MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes | Journal of Hepatology | 2008 | 96 |
| PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice | British Journal of Cancer | 2012 | 89 |
| Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease | Advances in Experimental Medicine and Biology | 2018 | 73 |
| Hepatotoxic slimming aids and other herbal hepatotoxins | Journal of Gastroenterology and Hepatology (Australia) | 2008 | 72 |
| The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups | Journal of Gastroenterology and Hepatology (Australia) | 2018 | 71 |
| Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease | Alimentary Pharmacology and Therapeutics | 2015 | 69 |
| Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection | Journal of Gastroenterology and Hepatology (Australia) | 2008 | 67 |
| Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly | Current Gerontology and Geriatrics Research | 2011 | 62 |
| Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways | Journal of Hepatology | 2008 | 62 |
| Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review | Journal of Gastroenterology and Hepatology (Australia) | 2013 | 60 |
| Impact of colonoscopy bowel preparation on intestinal microbiota | PLoS ONE | 2013 | 60 |
